Works about OVARIAN cancer
Results: 5000
Safety and efficacy of Rucaparib in the treatment of ovarian cancer and patients with BRCA mutation: a systematic review and meta-analysis of phase III randomized clinical trials.
- Published in:
- Expert Review of Anticancer Therapy, 2024, v. 24, n. 1/2, p. 71, doi. 10.1080/14737140.2024.2309177
- By:
- Publication type:
- Article
Comparison of poly (ADP-ribose) polymerase inhibitors (PARPis) as maintenance therapy for newly-diagnosed and platinum-sensitive recurrent ovarian cancer with BRCA mutational status: a systematic review and network meta-analysis.
- Published in:
- Expert Review of Anticancer Therapy, 2024, v. 24, n. 1/2, p. 59, doi. 10.1080/14737140.2023.2298832
- By:
- Publication type:
- Article
SEXUALITY AND OVARIAN CANCER.
- Published in:
- Canadian Journal of Human Sexuality, 1994, v. 3, n. 2, p. 123
- By:
- Publication type:
- Article
Prognostic impact of renin-angiotensin system inhibitors in patients with ovarian cancer: a meta-analysis of real-world evidence.
- Published in:
- Expert Review of Anticancer Therapy, 2025, v. 25, n. 3, p. 241, doi. 10.1080/14737140.2025.2463486
- By:
- Publication type:
- Article
Activation of ferritin light chain (FTL) by transcription factor salmonella pathogenicity island 1 modulates glycolysis to drive metastasis of ovarian cancer cells.
- Published in:
- Expert Review of Anticancer Therapy, 2024, v. 24, n. 12, p. 1271, doi. 10.1080/14737140.2024.2439558
- By:
- Publication type:
- Article
Statin use and ovarian cancer outcomes.
- Published in:
- Expert Review of Anticancer Therapy, 2024, v. 24, n. 12, p. 1199, doi. 10.1080/14737140.2024.2426551
- By:
- Publication type:
- Article
Evaluating the efficacy and safety of trebananib in treating ovarian cancer and non-ovarian cancer patients: a meta-analysis and systematic review.
- Published in:
- Expert Review of Anticancer Therapy, 2024, v. 24, n. 9, p. 881, doi. 10.1080/14737140.2024.2377793
- By:
- Publication type:
- Article
Treatment options in the advanced and recurrent setting for endometrial cancer: an update.
- Published in:
- Expert Review of Anticancer Therapy, 2024, v. 24, n. 8, p. 731, doi. 10.1080/14737140.2024.2370377
- By:
- Publication type:
- Article
Relacorilant in recurrent ovarian cancer: clinical evidence and future perspectives.
- Published in:
- Expert Review of Anticancer Therapy, 2024, v. 24, n. 8, p. 649, doi. 10.1080/14737140.2024.2362178
- By:
- Publication type:
- Article
Is there a link between talcum powder, oxidative stress, and ovarian cancer risk?
- Published in:
- Expert Review of Anticancer Therapy, 2024, v. 24, n. 7, p. 485, doi. 10.1080/14737140.2024.2352506
- By:
- Publication type:
- Article
Chronic conditions, cancer disparities, and the unique needs of Black women with ovarian cancer.
- Published in:
- Cancer (0008543X), 2025, v. 131, n. 3, p. 1, doi. 10.1002/cncr.35735
- By:
- Publication type:
- Article
Burden of female‐specific cancers in China from 1990 to 2021: A systematic analysis for the Global Burden of Disease Study 2021.
- Published in:
- Cancer (0008543X), 2025, v. 131, n. 2, p. 1, doi. 10.1002/cncr.35712
- By:
- Publication type:
- Article
Olaparib as treatment for platinum‐sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency: Phase 2 LIGHT study final overall survival analysis.
- Published in:
- Cancer (0008543X), 2025, v. 131, n. 2, p. 1, doi. 10.1002/cncr.35707
- By:
- Publication type:
- Article
Individual and Joint Associations of Depression‐Related Symptoms and Sleep Quality With Overall Survival Among Patients With Ovarian Cancer: Evidence From a Prospective Cohort Study.
- Published in:
- Depression & Anxiety (1091-4269), 2025, v. 2025, p. 1, doi. 10.1155/da/4907389
- By:
- Publication type:
- Article
Disruption of the FOXM1 Regulatory Region Inhibits Tumor Progression in Ovarian Cancer by CRISPR‐Cas9.
- Published in:
- Drug Development Research, 2025, v. 86, n. 1, p. 1, doi. 10.1002/ddr.70049
- By:
- Publication type:
- Article
Current practices and challenges in genetic testing and counseling for women with breast and ovarian cancer in Asia.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2025, v. 21, n. 2, p. 211, doi. 10.1111/ajco.14074
- By:
- Publication type:
- Article
Return to intended oncological therapy following advanced ovarian cancer surgery: a narrative review.
- Published in:
- Anaesthesia, 2025, v. 80, n. S2, p. 106, doi. 10.1111/anae.16521
- By:
- Publication type:
- Article
Better Outcomes for Ovarian Cancer Associated With the Detection of Anti‐EBV TCR CDR3s: Potential Relevance to Diffuse Large B‐Cell Lymphoma.
- Published in:
- American Journal of Reproductive Immunology, 2025, v. 93, n. 1, p. 1, doi. 10.1111/aji.70046
- By:
- Publication type:
- Article
No Bacterial Biomass Detected in Tissue From Patients With Ovarian Cancer and Serous Tubal Intraepithelial Carcinomas Using 16S rDNA Sequencing.
- Published in:
- APMIS, 2025, v. 133, n. 1, p. 1, doi. 10.1111/apm.13509
- By:
- Publication type:
- Article
Pooled Nanoparticle Screening Using a Chemical Barcoding Approach.
- Published in:
- Angewandte Chemie, 2025, v. 137, n. 5, p. 1, doi. 10.1002/ange.202420052
- By:
- Publication type:
- Article
'I was eager to do anything I could to improve the situation': a qualitative study of patients' experiences and views of prehabilitation for ovarian cancer surgery.
- Published in:
- BMC Women's Health, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12905-025-03630-5
- By:
- Publication type:
- Article
WTAP contributes to platinum resistance in high-grade serous ovarian cancer by up-regulating malic acid: insights from liquid chromatography and mass spectrometry analysis.
- Published in:
- Cancer & Metabolism, 2025, v. 13, n. 1, p. 1, doi. 10.1186/s40170-025-00383-5
- By:
- Publication type:
- Article
ESM1 suppresses LncRNA GAS5/miR-23a-3p/PTEN axis to promote the cisplatin-chemotherapy resistance of ovarian cancer cells via activating the PI3K/AKT pathway.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02113-1
- By:
- Publication type:
- Article
Transcription factor networks and novel immune biomarkers reveal key prognostic and therapeutic insights in ovarian cancer.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-01788-w
- By:
- Publication type:
- Article
Network pharmacology combined with molecular docking and experimental validation of the mechanism of action of columbianetin acetate in the treatment of ovarian cancer.
- Published in:
- Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1515976
- By:
- Publication type:
- Article
Compound cancer with small cell carcinoma and mucinous adenocarcinoma of the ovary: a case report and literature review.
- Published in:
- Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1500088
- By:
- Publication type:
- Article
Diagnostic value of magnetic resonance imaging for malignant ovarian tumors mis-subclassified by the ultrasound-based ADNEX model.
- Published in:
- Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1406735
- By:
- Publication type:
- Article
Big data analysis and machine learning of the role of cuproptosis-related long non-coding RNAs (CuLncs) in the prognosis and immune landscape of ovarian cancer.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1555782
- By:
- Publication type:
- Article
IMPACT OF BRCA GENES MUTATION ON GYNECOLOGICAL DISORDERS: BEYOND ONCOLOGICAL RISK.
- Published in:
- Environmental & Social Management Journal / Revista de Gestão Social e Ambiental, 2025, v. 19, n. 2, p. 1, doi. 10.24857/rgsa.v19n2-031
- By:
- Publication type:
- Article
Risk factors for postoperative hypoalbuminemia in ovarian cancer: a predictive nomogram.
- Published in:
- BMC Women's Health, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12905-025-03650-1
- By:
- Publication type:
- Article
Olaparib increases chemosensitivity by upregulating miR-125a-3p in ovarian cancer cells.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02048-7
- By:
- Publication type:
- Article
Advances in S100 protein family for gynecological malignancies.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02028-x
- By:
- Publication type:
- Article
Efficient Gene Expression Data Analysis using ES-DBN For Microarray Cancer Data Classification.
- Published in:
- EAI Endorsed Transactions on Pervasive Health & Technology, 2024, v. 10, n. 1, p. 1, doi. 10.4108/eetpht.10.6187
- By:
- Publication type:
- Article
PEG-functionalized UiO-66 MOFs for targeted vincristine delivery: enhanced cytotoxicity in breast and ovarian cancer cell lines.
- Published in:
- Cancer Nanotechnology (1868-6958), 2025, v. 16, n. 1, p. 1, doi. 10.1186/s12645-025-00315-4
- By:
- Publication type:
- Article
Secondary cytoreductive surgery in platinum-sensitive relapsed ovarian cancer: a meta-analysis of randomized controlled trials.
- Published in:
- Archives of Gynecology & Obstetrics, 2025, v. 311, n. 2, p. 405, doi. 10.1007/s00404-024-07863-x
- By:
- Publication type:
- Article
Unravelling the association between metformin and pan-cancers: Mendelian randomization combined with NHANES database analysis.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02021-4
- By:
- Publication type:
- Article
Improving real-world evaluation of patient- and physician-reported tolerability: niraparib for recurrent ovarian cancer (NiQoLe).
- Published in:
- JNCI Cancer Spectrum, 2025, v. 9, n. 1, p. 1, doi. 10.1093/jncics/pkae114
- By:
- Publication type:
- Article
Expectations and Challenges of First-Line Maintenance Therapy for Advanced Ovarian Cancer.
- Published in:
- Medicina (1010660X), 2021, v. 57, n. 5, p. 501, doi. 10.3390/medicina57050501
- By:
- Publication type:
- Article
Advanced Ovarian Cancer during Pregnancy. Tumour Evolution Analysis and Treatment Approach.
- Published in:
- Medicina (1010660X), 2021, v. 57, n. 5, p. 426, doi. 10.3390/medicina57050426
- By:
- Publication type:
- Article
Complete response to Mirvetuximab Soravtansine in platinum-resistant recurrent ovarian cancer: a case report.
- Published in:
- Journal of Ovarian Research, 2025, v. 18, n. 1, p. 1, doi. 10.1186/s13048-025-01628-z
- By:
- Publication type:
- Article
Mechanism of microRNA-152-3p-Mediated Regulation of Autophagy and Sensitivity in Paclitaxel-Resistant Ovarian Cancer Cells.
- Published in:
- OncoTargets & Therapy, 2025, v. 18, p. 179, doi. 10.2147/OTT.S485100
- By:
- Publication type:
- Article
Efficacy and Safety of Low-Dose Lenvatinib and Toripalimab in Patients With Recurrent Platinum-Resistant Ovarian Cancer: Study Protocol of a Multicenter, Open-Label, Single-Arm, Phase II Clinical Trial.
- Published in:
- International Journal of Women's Health, 2025, v. 17, p. 325, doi. 10.2147/IJWH.S502665
- By:
- Publication type:
- Article
Predictive Value of PLR, PNI, and HALP Scores in Ovarian Cancer Staging.
- Published in:
- Cancer Management & Research, 2025, v. 17, p. 293, doi. 10.2147/CMAR.S508442
- By:
- Publication type:
- Article
Development of model for identifying homologous recombination deficiency (HRD) status of ovarian cancer with deep learning on whole slide images.
- Published in:
- Journal of Translational Medicine, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12967-025-06234-7
- By:
- Publication type:
- Article
scPAS: single-cell phenotype-associated subpopulation identifier.
- Published in:
- Briefings in Bioinformatics, 2025, v. 26, n. 1, p. 1, doi. 10.1093/bib/bbae655
- By:
- Publication type:
- Article
Characterization of Са<sup>2+</sup>,Мg<sup>2+</sup>-ATPase of blood lymphocytes in women with ovarian cancer.
- Published in:
- Regulatory Mechanisms in Biosystems, 2018, v. 9, n. 1, p. 85, doi. 10.15421/021812
- By:
- Publication type:
- Article
Targeting HSP90 in Gynecologic Cancer: Molecular Mechanisms and Therapeutic Approaches.
- Published in:
- Cell Biochemistry & Biophysics, 2025, v. 83, n. 1, p. 177, doi. 10.1007/s12013-024-01502-7
- By:
- Publication type:
- Article
Advancements in Hydrogel-Based Therapies for Ovarian Cancer: A Review.
- Published in:
- Cell Biochemistry & Biophysics, 2025, v. 83, n. 1, p. 87, doi. 10.1007/s12013-024-01483-7
- By:
- Publication type:
- Article
Potential Efficacy of Inflammatory Response Markers for the Detection of Ovarian Cancer in Patients with Endometrioma.
- Published in:
- Yonago Acta Medica, 2025, v. 68, n. 1, p. 51, doi. 10.33160/yam.2025.02.006
- By:
- Publication type:
- Article
Therapeutic potential of Achillea millefolium L. extract on 7,12-dimethylbenz(a)anthracene (DMBA) -induced ovary cancer in Wistar rats: a biochemical, molecular and histopathological approach.
- Published in:
- Toxicology Research, 2025, v. 14, n. 1, p. 1, doi. 10.1093/toxres/tfae235
- By:
- Publication type:
- Article